CDRE vs PFE · P/E 36, rev $567.6M vs P/E 20, rev $62.58B
Cadre Holdings Inc (CDRE) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Cadre Holdings Inc (CDRE) is a aerospace & defense company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported CDRE revenue for 2024-12-31 was $567.6M. Net income was $36.1M. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. CDRE currently screens at market cap $1.28B and trailing P/E 35.7.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
CDRE currently screens at market cap $1.28B and trailing P/E 35.7. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the CDRE and PFE stock pages for the full models.
Not investment advice.